Active, Not Recruiting
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
NCT06851559
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- Preferred Research Partners, Inc Little Rock, Arkansas, United States
- GW Research, Inc Chula Vista, California, United States
- Southern California Research Institute Medical Group Los Angeles, California, United States
- Rocky Mountain Gastroenterology Lakewood, Colorado, United States